Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries SciSparc Ltd. - Ordinary Shares (NQ: SPRC ) 0.8000 -0.0510 (-5.99%) Streaming Delayed Price Updated: 3:58 PM EDT, Jun 28, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 74,974 Open 0.8511 Bid (Size) 0.7703 (12) Ask (Size) 0.8298 (3) Prev. Close 0.8510 Today's Range 0.8000 - 0.8511 52wk Range 0.8000 - 15.86 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News SciSparc Secures Strategic Advantage with Grant of European Patent May 31, 2024 From SciSparc Ltd Via GlobeNewswire Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 16, 2024 Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates. Via Benzinga Performance YTD -84.28% -84.28% 1 Month -23.81% -23.81% 3 Month -56.99% -56.99% 6 Month -84.28% -84.28% 1 Year -94.39% -94.39% More News Read More Why Macatawa Bank Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket April 16, 2024 Via Benzinga Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session April 11, 2024 Via Benzinga SciSparc To Acquire AutoMax, A Strategic Leap Towards Industry Diversification April 11, 2024 Via Benzinga SciSparc to Acquire AutoMax April 11, 2024 From SciSparc Ltd Via GlobeNewswire Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket April 11, 2024 Via Benzinga SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression March 27, 2024 From SciSparc Ltd Via GlobeNewswire SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer Research March 21, 2024 From SciSparc Ltd Via GlobeNewswire SciSparc Granted Another Patent, Strengthening its Core Technology in Canada March 18, 2024 From SciSparc Ltd Via GlobeNewswire SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial March 14, 2024 From SciSparc Ltd Via GlobeNewswire Podcast: Clearmind's Non-Hallucinogenic Psychoactive Molecule Could Become A Solution For Addictive Behaviors March 12, 2024 Via Benzinga SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure March 12, 2024 From SciSparc Ltd Via GlobeNewswire Autism CBD Trial Enrolls Children: This Israeli Co. Is Making Headway In New Treatments March 08, 2024 Via Benzinga Topics Intellectual Property Exposures Intellectual Property SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum Disorder March 08, 2024 From SciSparc Ltd Via GlobeNewswire SciSparc Granted Patent for Core Technology in Multiple Jurisdictions in Europe March 07, 2024 From SciSparc Ltd Via GlobeNewswire SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology March 06, 2024 From SciSparc Ltd Via GlobeNewswire Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More March 04, 2024 Via Benzinga SciSparc Delivers Treatment for Autism Spectrum Disorder Clinical Trial Enabling Commencement of Dosing February 29, 2024 From SciSparc Ltd Via GlobeNewswire SciSparc-Clearmind Partnership Yields Three New International Patent Applications for MDMA, Ibogaine and Ketamine Compounds February 27, 2024 From SciSparc Ltd Via GlobeNewswire Clearmind Medicine Submits Three Additional International Patent Applications for Innovative MDMA, Ibogaine and Ketamine Compounds February 27, 2024 From Clearmind Medicine Inc. Via GlobeNewswire EXCLUSIVE: Psychedelic-Focused Firm Clearmind Medicine Submits Three New International Patent Applications For MDMA, Ibogaine And Ketamine Compounds February 27, 2024 Via Benzinga Topics Intellectual Property Exposures Intellectual Property Next-Gen Psychedelics Companies SciSparc And Clearmind Collaboration File 3 Patents February 21, 2024 Via Benzinga Topics Intellectual Property Exposures Intellectual Property What's Going On With Psychedelic Drug-Developers SciSparc And Clearmind Stock? February 20, 2024 Via Benzinga Topics Intellectual Property Exposures Intellectual Property Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session February 20, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.